The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Self-reported race and zip code by men with prostate cancer in New York City and association with access to PSMA PET scans.
 
Jones T. Nauseef
Travel, Accommodations, Expenses - Digital Science Press
 
Juana Martinez Zuloaga
No Relationships to Disclose
 
Kritika Subramanian
No Relationships to Disclose
 
Peter Gregos
No Relationships to Disclose
 
Mahelia Bissassar
No Relationships to Disclose
 
Sharon Singh
No Relationships to Disclose
 
Amie Patel
No Relationships to Disclose
 
Angela Tan
No Relationships to Disclose
 
Ted Getz
No Relationships to Disclose
 
Brian Labadie
No Relationships to Disclose
 
Matthew Dallos
No Relationships to Disclose
 
Cora N. Sternberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Foundation Medicine; Genzyme; Immunomedics; IMPAC Medical Systems; Incyte; Medscape; Merck; MSD; Pfizer; Roche; UroToday
 
David M. Nanus
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); immumedics (Inst); Janssen (Inst); Novartis (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
 
Neil Harrison Bander
Leadership - Convergent Therapeutics; XenImmune Therapeutics
Stock and Other Ownership Interests - Convergent Therapeutics; Telix Pharmaceuticals; XenImmune Therapeutics
Consulting or Advisory Role - Convergent Therapeutics; Tarveda Therapeutics; XenImmune Therapeutics
Patents, Royalties, Other Intellectual Property - Patents to anti-PSMA antibodies assigned to Cornell Univ; Royalty--Cook Urological
 
Sandra Huicochea Castellanos
No Relationships to Disclose
 
Daniel Margolis
Consulting or Advisory Role - Blue Earth Diagnostics; Promaxo
Research Funding - Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Joseph Osborne
No Relationships to Disclose
 
Scott T. Tagawa
Consulting or Advisory Role - 4D Pharma; Abbvie; AIkido Pharma; Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clarity Pharmaceuticals; Clovis Oncology; Convergent Therapeutics; Dendreon; Endocyte; Genentech; Genomic Health; Gilead Sciences; Immunomedics; Janssen; Karyopharm Therapeutics; Medivation; Myovant Sciences; Novartis; Pfizer; POINT Biopharma; QED Therapeutics; Sanofi; Seagen; Telix Pharmaceuticals; Tolmar
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); POINT Biopharma (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - Patent Royalty from Immunomedics / Gilead
Travel, Accommodations, Expenses - Amgen; Immunomedics; Sanofi
(OPTIONAL) Uncompensated Relationships - ATLAB Pharma; Phosplatin Therapeutics